Norovirus Costs the U.S. $10.6 Billion a Year
Norovirus is the leading cause of acute gastroenteritis in the United States, infecting an estimated 19–21 million people annually. The economic burden reaches $10.6 billion per year — and 89% of that is lost productivity, not medical bills.
Written and researched by Andy Wilcox · Last reviewed: June 2026
The Headline Figure
A 2020 analysis by Bartsch et al., published in the Journal of Infectious Diseases (vol. 222, issue 11, DOI: 10.1093/infdis/jiaa292), estimated the total annual U.S. societal cost of norovirus at approximately $10.6 billion. The structure of that cost is striking:
(missed work, caregiving, premature death)
(visits, hospitalization, treatment)
The productivity-dominated cost structure — where indirect losses from missed workdays swamp direct medical spending — makes norovirus economically unlike most other infectious diseases, where health-system costs are the primary driver. This pattern holds because norovirus is highly contagious, nearly universal in incidence, usually self-limiting (so formal medical care is often not sought), and concentrated in economically active populations.
Adults aged 45 and older account for more than half of total productivity losses, per the Bartsch 2020 analysis — reflecting both higher workforce participation in that cohort and the greater severity of norovirus illness in older adults.
The Foodborne Slice: $2–2.3 Billion Per Year
Not all norovirus transmission is foodborne — person-to-person spread is in fact the dominant route, particularly in institutional settings. But the foodborne component has its own, separately quantified economic burden:
- The CDC estimates approximately $2 billion per year in U.S. economic costs attributable specifically to foodborne norovirus.
- A USDA Economic Research Service (USDA ERS) analysis ranked norovirus 4th among 15 major foodborne pathogens by annual economic cost, at approximately $2.3 billion per year. Source: USDA ERS chart data.
The foodborne cost falls disproportionately on the food service industry, which faces direct costs from contamination events (discarded food, facility cleaning and closure, staff illness) and indirect costs from reputational damage and consumer avoidance following publicly reported outbreaks.
Outbreak Settings and Their Specific Costs
Norovirus outbreaks cluster in settings where people eat communally, share close quarters, or both. Each setting has a distinct economic profile:
Cruise ships
Cruise-ship norovirus outbreaks are among the most visible because CDC Vessel Sanitation Program data are public, and media coverage is extensive. The economic costs include: health-care provision on board, early debarkation of ill passengers, partial-voyage refunds, accelerated deep cleaning between voyages, and the reputational effect on future bookings. The CDC has documented dozens of cruise outbreaks per year in U.S.-accessible waters.
Long-term care facilities
Nursing homes and assisted-living facilities are the highest-severity norovirus setting. Older adults in congregate care face higher hospitalization rates from norovirus than the general population; outbreak response involves cohorting ill residents, staff reassignment, visitor restriction, and the direct and indirect costs of increased nursing intensity. Norovirus is the leading cause of acute gastroenteritis outbreaks in long-term care settings, per CDC surveillance.
Schools and childcare
School-based norovirus outbreaks impose large productivity costs on parents who must leave work to care for sick children or pick them up early. A single school outbreak affecting hundreds of students can result in thousands of aggregate parent-workday losses — a cost that never appears in health-system data but is real and significant.
Food service and restaurants
Infected food handlers are a primary vector for restaurant-linked outbreaks. Outbreak investigations regularly trace norovirus transmission to a single symptomatic employee who worked while ill — a behavior driven partly by lack of paid sick leave. The economic cost of this pathway includes the outbreak response, liability exposure, and the lasting reputational impact on the establishment.
Global Economic Burden
A 2016 analysis by Bartsch et al. in PLOS ONE (DOI: 10.1371/journal.pone.0151219) estimated the global annual economic burden of norovirus gastroenteritis at approximately $4.2 billion in direct health-system costs (95% UI: $3.2–5.7B) and $60.3 billion in total societal costs including productivity losses (95% UI: $44.4–83.4B).
The gap between U.S. and global figures illustrates a familiar pattern in infectious-disease economics: the U.S. per-case cost is high because of high health-system prices and high nominal wages (making productivity losses expensive in dollar terms). Low-income countries bear substantial norovirus burden — it is one of the leading causes of childhood diarrheal disease globally — but the dollar-denominated economic cost appears smaller because wages and health-system costs are lower. Burden measured in disability-adjusted life years (DALYs) rather than dollars would show a different distribution.
Sources & References
- Bartsch SM et al. Clinical and Economic Burden of Norovirus Gastroenteritis in the United States. Journal of Infectious Diseases. 2020;222(11):1910–1919. DOI: 10.1093/infdis/jiaa292
- Bartsch SM et al. Global Economic Burden of Norovirus Gastroenteritis. PLOS ONE. 2016;11(4):e0151219. DOI: 10.1371/journal.pone.0151219
- USDA Economic Research Service. Cost Estimates of Foodborne Illnesses. ers.usda.gov
- CDC. Norovirus: About Norovirus. cdc.gov/norovirus
- CDC Vessel Sanitation Program. Outbreak Updates for International Cruise Ships. cdc.gov/nceh/vsp